In its letter the Delhi government's Director of Vigilance wrote "It also needs to be investigated whether the same drugs which have been procured by the Central Procurement Agency (CPA) are also being distributed to the patients through the 'Mohalla Clinics' or not". The letter further said that any action for supplying 'Not of Standard Quality' drugs should not be confined to the CPA and there is need to investigate the entire supply chain -- the role of the suppliers who procured from manufacturers and provided supply to the end users, that is, hospitals (patients).
